| ¿µ¹® | adverse effect | ÇÑ±Û | ¿ªÈ¿°ú, À¯ÇØÈ¿°ú |
|---|---|---|---|
| ¼³¸í | ¾à¹°¿¡ ÀÇÇÑ Ä¡·á¸¦ ÇÒ ¶§ ³ªÅ¸³ª´Â Ä¡·á¸ñÀû¿¡ ºÎÇÕµÇÁö ¾Ê´Â ºÒÄèÇÑ ÀÛ¿ë, Áï ºÎÀÛ¿ëÀ» ¿ªÈ¿°ú·Î Ç¥ÇöÇÏ´Â °æ¿ì°¡ ÀÖ´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡¼´Â ¿ªÈ¿°ú¶õ ¡°¿¹¹æ, Áø´Ü, Ä¡·áÀÇ ¸ñÀûÀ¸·Î »ç¶÷¿¡°Ô »ó¿ë·®ÀÇ ¾àÀ» »ç¿ëÇÏ¿´À» ¶§ ¹ßÇöÇÏ´Â Àå¾Ö·Î, ÀǵµÇÏÁö ¾ÊÀº Àۿ롱À̶ó°í Á¤ÀÇÇϰí ÀÖ´Ù. ¾à¹°¿¡ ÀÇÇÑ Ä¡·á¸¦ ÇÒ ¶§, ƯÈ÷ ÁÖ¸ñÇÏ¿©¾ß ÇÒ ÀϹÝÀûÀÎ ¿ªÈ¿°ú·Î¼ ¾à¹°¾Ë·¹¸£±â, Á¶Ç÷Àå±â Àå¾Ö, °£-ÄáÆÏÀÇ Àå¾Ö, ¹°Áú ´ë»ç Àå¾Ö µîÀÌ ÀÖ´Ù. ÀÌ ¿Ü¿¡ ÀÓ»êºÎ¿¡°Ô Åõ¿©ÇÏ¿© ¹ß»ýÇÑ ±âÇü¹ß»ý, ¸¶¾à, °¢¼ºÁ¦, ±âŸ ÇâÁ¤½ÅÁ¦¿¡ ÀÇÇÑ ÀÇÁ¸¼º Çü¼ºµµ Áß¿äÇÏ´Ù. |
||
| PL | PLatelet phospholipid |
|---|---|
| BPC | Behavior Problem Checklist; bile phospholipid concentration; blood pressure cuff; British Pharmaceut... |
| C/P | cholesterol-phospholipid [ratio] |
| C/PL | cholesterol/phospholipid [ratio] |
| EPL | effective patient's life; equivalent path length; essential phospholipid; extensor pollicis longus; ... |
| APA | Anti phospholipid antibody |
|---|---|
| aPL | Anti-phospholipid |
| APS | Anti-phospholipid Antibody Syndrome |
| APS | Anti-phospholipid Syndrome |
| APA | Anti-phospholipid antibodies |
| acyl-(acyl-carrier-protein)-phospholipid acyltransferase | <enzyme> Catalyses the formation of phosphatidylethanolamine from acyl-acyl carrier protein and 2-acyl-sn-glycero-3-phosphoethanolamine Registry number: EC 2.3.1.40 Synonym: 2-acyl-gpe acyltransferase, 2-acylglycerophosphoethanolamine acyltransferase (26 Jun 1999) |
|---|---|
| phospholipid | <biochemistry> The major structural lipid of most cellular membranes (except the chloroplast which has galactolipids). Contain phosphate, usually as a diester. Examples include phosphatidyl phospholipids, plasmalogens and sphingomyelins. (18 Nov 1997) |
| phospholipid bilayer | <biochemistry> A lamellar organisation of phospholipids that are packed as a bilayer with hydrophobic acyl tails inwardly directed and polar head groups on the outside surfaces. It is this bilayer that forms the basis of membranes in cells, though in most cellular membranes a very substantial proportion of the area may be occupied by integral proteins. The triple layered appearance of membranes seen in electron microscopy is thought to arise because the osmium tetroxide binds to the polar regions leaving a central, unstained, hydrophobic region. (31 Dec 1997) |
| phospholipid ethers | Phospholipids which have an alcohol moiety in ethereal linkage with a saturated or unsaturated aliphatic alcohol. They are usually derivatives of phosphoglycerols or phosphatidates. The other two alcohol groups of the glycerol backbone are usually in ester linkage. These compounds are widely distributed in animal tissues. (12 Dec 1998) |
| phospholipid-hydroperoxide glutathione peroxidase | <enzyme> Selenoenzyme found in biological materials; different from glutathione peroxidase EC 1.11.1.9 Registry number: EC 1.11.1.- Synonym: pH-gperoxidase (26 Jun 1999) |
| phospholipid syndrome | <syndrome> The combination of antiphospholipid antibodies and the presence of either arterial or venous occlusive events such as thrombosis. (05 Mar 2000) |
| phospholipid transfer protein | <protein> Cytoplasmic proteins that bind phospholipids and facilitate their transfer between cellular membranes. May also cause net transfer from the site of synthesis. (18 Nov 1997) |
| abscopal effect | A reaction produced following irradiation but occurring outside the zone of actual radiation absorption. (05 Mar 2000) |
| additive effect | <biochemistry, chemistry> An additive effect is the overall biological effect two chemicals acting together and which is the simple sum of the effects of the chemicals acting independently. Compare: antagonism. (15 Jan 1998) |
| adverse effect | This is an abnormal or harmful effect to an organism caused by exposure to a chemical. It is indicated by some result such as death, a change in food or water consumption, altered body and organ weights, altered enzyme levels, or visible illness. An effect may be classed as adverse if it causes functional or anatomical damage, causes irreversible change in the homeostasis of the organism, or increases the susceptibility of the organism to other chemical or biological stress. A non-adverse effect will usually be reversed when the organism is no longer being exposed to the chemical. (09 Oct 1997) |
| Anrep effect | A small transient positive inotropic effect of abrupt increases of systolic aortic and left ventricular pressures related to recovery from transient subendocardial ischemia (e.g., cold pressor test). (05 Mar 2000) |
| antagonistic effect | This is the consequence of one chemical (or group of chemicals) counteracting the effects of another chemical, the opposing chemicals cancel out each other's effects. (09 Oct 1997) |
| Arias-Stella effect | Focal, unusual, decidual changes in endometrial epithelium, consisting of intraluminal budding, and nuclear enlargement and hyperchromatism with cytoplasmic swelling and vacuolation; may be associated with ectopic or uterine pregnancy. Synonym: Arias-Stella effect, Arias-Stella reaction. (05 Mar 2000) |
| Auger effect | <physics> Transition of an electron in an atom from a discrete electronic level to an ionised continuous level with the same energy. Synonym: autoionisation. (13 Jan 1998) |
| autokinetic effect | In psychology, the apparent drifting about of a small, fixed, spot of light which is being observed in a dark room. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|